Government
The only other drug currently approved in the U.S. for HIV PrEP is Gilead’s Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg).
Trump said that the pharma industry was looking for payback due to his administration’s efforts to lower the costs of prescription drugs.
The NOAA RESTORE Science Program has awarded approximately $15.6 million in grants to four teams of researchers and resource managers from across 20 institutions including universities, federal and state agencies and non-governmental organizations to support work on living coastal and marine resources and their habitats in the Gulf of Mexico.
According to multiple reports, President Donald Trump is set to pick Hahn, a noted radiation oncologist, as the successor to Scott Gottlieb.
Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research grant from the National Cancer Institute of the National Institutes of Health under Award Number R43CA233155.
The U.S. Food and Drug Administration (FDA) rejected the company’s inhaled triple-combination therapy, PT010, now known as Breztri Aerosphere.
Janssen’s Invokana snagged another regulatory approval to reduce the risk of end-stage kidney disease, cardiovascular death and worsening of kidney function in adults with type 2 diabetes and diabetic kidney disease.
Studies on a novel protein that helps cancer cells to grow and spread may help in the development of more efficient therapies for liver cancer
The FDA’s latest approval for Darzalex is based on results from the Phase III CASSIOPEIA trial that showed the addition of Darzalex to VTd before and after ASCT resulted in deeper responses in patients with the blood cancer.
AbbVie’s Mayvret won expanded approval from the U.S. Food and Drug Administration to shorten the one-daily treatment duration from 12 to eight weeks in treatment-naïve hepatitis C patients without cirrhosis and with compensated cirrhosis.
PRESS RELEASES